MedTrace Logo

Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder

NCT01815099 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2017-04-10

Study results available
· View outcomes & findings →

Summary

We are investigating the feasibility and efficacy of transcranial magnetic stimulation (TMS) for patients with GAD who were placebo nonresponders in DIEF003523.1.

Conditions

  • Generalized Anxiety Disorder

Interventions

DEVICE

rTMS Treatment

Either 10 or 15 rTMS sessions (2 or 3 times/week for 5 weeks, respectively)

Sponsors & Collaborators

  • Neuronetics

    collaborator OTHER

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Gretchen J Diefenbach, Ph.D. · Hartford Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01815099 on ClinicalTrials.gov